V
Vanda Pharmaceuticals Inc.
VNDA · NASDAQ · Healthcare · 314M
Price · close
$5.28
-1.86% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
1.0×
Enterprise value / EBITDAEV/EBITDA
-1.9×
Free cash flow yieldFCF yield
-35.5%
Return on equityROE
-67.4%
Operating margin
-70.0%
Net debt / EBITDAbalance-sheet strength
0.6×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.